Vanda Pharmaceuticals Cash Flow Statement (2009-2025) | VNDA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	8.63M	9.60M	7.77M	7.10M	-6.46M	2.57M	3.26M	6.86M	3.25M	1.49M	0.14M	-2.40M	-4.15M	-4.52M	-5.34M	-4.88M	-29.47M	-27.21M	-22.59M	-141.23M
Depreciation and Depletion (Quarter)	0.34M	0.34M	0.34M	0.37M	0.32M	0.31M	0.30M	0.28M	0.29M	0.22M	0.20M	0.20M	0.21M	0.22M	0.22M	0.26M	0.23M	0.27M	0.30M	0.30M
Share-based Compensation (Quarter)	3.91M	3.74M	3.95M	3.77M	4.78M	3.83M	3.89M	3.78M	4.35M	3.25M	3.17M	3.27M	3.58M	2.99M	3.00M	2.86M	2.97M	2.11M	2.11M	2.29M
Deferred Taxes (Quarter)	1.16M	1.75M	2.53M	1.31M	4.42M	-1.87M	-1.84M	0.42M	2.01M	1.46M	2.73M	-7.48M	-0.25M	-1.23M	-3.09M	-1.91M	-7.80M	-7.97M	-5.97M	103.19M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)	-0.29M	-0.37M	-0.56M	-0.51M	-0.55M	-0.42M	-0.64M	-0.84M	-1.11M	-0.73M	-0.93M	0.68M					0.92M	-0.08M	0.08M	-2.86M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	9.19M	19.02M	9.40M	26.61M	4.05M	5.68M	12.84M	9.42M	31.80M	-13.22M	-2.05M	-3.73M	7.57M	-6.93M	-14.58M	-1.82M	-33.15M	-15.25M	-31.63M	-29.42M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.40M	0.40M	0.40M	2.93M	0.38M	0.38M	0.40M	1.86M	0.40M	0.38M	0.38M	-4.96M	2.02M	1.75M	1.75M	1.49M	1.80M	1.75M	1.80M	5.21M
Depreciation & Amortization (CF) (Quarter)	0.34M	0.34M	0.34M	0.37M	0.32M	0.31M	0.30M	0.28M	0.29M	0.22M	0.20M	0.20M	0.21M	0.22M	0.22M	0.26M	0.23M	0.27M	0.30M	0.30M
Change in Working Capital
Change in Receivables (Quarter)	1.48M	5.58M	4.42M	-9.02M	-1.96M	-1.62M	0.59M	4.07M	-8.90M	9.10M	-4.33M	4.84M	2.59M	5.16M	0.83M	4.43M	-2.53M	0.35M	5.57M	4.08M
Change in Inventory (Quarter)	-0.04M	1.41M	0.79M	0.08M	1.18M	0.40M	1.77M	1.13M	-0.07M	-0.14M	0.55M	0.43M	-0.03M	-0.26M	0.21M	0.11M	1.85M	0.37M	-0.03M	1.28M
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)	-5.27M	6.16M	-0.03M	2.18M	13.43M	0.31M	1.34M	-3.28M	-10.79M	-3.24M	-0.28M	3.33M	1.17M	3.14M	-0.47M	-2.13M	5.64M	11.33M	-10.22M	9.08M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)	-0.05M	1.60M	1.38M	-1.69M	13.36M	0.33M	-4.11M	-3.45M	-11.35M	2.82M	7.19M	-7.19M	-1.78M	1.30M	3.66M	3.64M	5.39M	1.44M	-0.70M	5.94M
Investing Activities
Capital Expenditures (Quarter)	0.13M	0.30M	-0.01M	0.13M	0.07M	0.19M	0.15M	0.26M	0.05M	0.06M	0.02M	0.25M	0.01M	0.11M	0.16M	0.21M	0.44M	0.30M	0.16M	0.10M
Change in Intangibles (Quarter)
Change in Acquisitions & Divestments (Quarter)	93.26M	70.41M	101.24M	79.41M	90.08M	82.45M	147.34M	80.00M	350.39M	57.09M	82.00M	112.11M	60.50M	99.00M	95.95M	96.61M	87.67M	38.00M	35.57M	47.00M
Cash from Investing Activities (Quarter)	0.07M	-34.18M	-16.59M	-26.00M	10.87M	-14.59M	-21.78M	75.43M	187.29M	-190.89M	35.33M	-43.78M	-18.22M	-15.26M	12.06M	3.99M	43.90M	-15.27M	21.36M	44.87M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)	1.85M	0.29M	0.37M	1.04M		0.12M	0.00M	0.60M								-0.15M	-1.32M	-0.42M	-0.52M	-0.64M
Additional items
Exchange Rate Effect (Quarter)	-0.01M	-0.01M	0.04M	-0.10M	-0.06M	0.08M	0.06M	0.18M	0.04M	-0.03M	-0.12M	0.15M	-0.01M	-0.01M	0.07M	-0.20M	0.05M	0.13M	-0.18M	0.02M
Change in Cash (Quarter)	11.10M	-14.89M	-6.78M	1.55M	14.86M	-8.70M	-8.88M	85.63M	219.14M	-204.14M	33.16M	-47.37M	-10.66M	-22.20M	-2.46M	1.82M	9.48M	-30.81M	-10.96M	14.83M
Free Cash Flow (Quarter)	9.06M	18.72M	9.41M	26.47M	3.97M	5.49M	12.69M	9.15M	31.75M	-13.28M	-2.07M	-3.98M	7.56M	-7.04M	-14.74M	-2.03M	-33.58M	-15.55M	-31.79M	-29.52M
Net Cash Flow (Quarter)	11.11M	-14.88M	-6.82M	1.65M	14.91M	-8.78M	-8.94M	85.45M	219.10M	-204.11M	33.28M	-47.52M	-10.65M	-22.19M	-2.52M	2.02M	9.43M	-30.95M	-10.78M	14.81M

Research Tools

Vanda Pharmaceuticals Cash Flow Statement (2009-2025) | VNDA

Create an account

Sign In

Reset Password